301 related articles for article (PubMed ID: 8841929)
1. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT
Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652
[TBL] [Abstract][Full Text] [Related]
5. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells.
Tyagi SC; Lewis K; Pikes D; Marcello A; Mujumdar VS; Smiley LM; Moore CK
J Cell Physiol; 1998 Aug; 176(2):374-82. PubMed ID: 9648925
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells.
Tyagi SC; Kumar SG; Alla SR; Reddy HK; Voelker DJ; Janicki JS
J Cell Physiol; 1996 Apr; 167(1):137-47. PubMed ID: 8698831
[TBL] [Abstract][Full Text] [Related]
7. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
8. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
[TBL] [Abstract][Full Text] [Related]
9. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.
Tyagi SC; Meyer L; Kumar S; Schmaltz RA; Reddy HK; Voelker DJ
Can J Cardiol; 1996 Apr; 12(4):353-62. PubMed ID: 8608454
[TBL] [Abstract][Full Text] [Related]
10. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
11. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells.
Tyagi SC; Kumar S; Katwa L
J Mol Cell Cardiol; 1997 Jan; 29(1):391-404. PubMed ID: 9040053
[TBL] [Abstract][Full Text] [Related]
13. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
14. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of extracellular matrix components in dilated cardiomyopathy.
Tyagi SC; Kumar S; Voelker DJ; Reddy HK; Janicki JS; Curtis JJ
J Cell Biochem; 1996 Nov; 63(2):185-98. PubMed ID: 8913870
[TBL] [Abstract][Full Text] [Related]
16. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
[TBL] [Abstract][Full Text] [Related]
17. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth.
Dannewitz B; Edrich C; Tomakidi P; Kohl A; Gabbert O; Eickholz P; Steinberg T
Cell Tissue Res; 2006 Sep; 325(3):513-22. PubMed ID: 16670920
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
Zhao YG; Xiao AZ; Cao XM; Zhu C
Mol Reprod Dev; 2002 Jun; 62(2):149-58. PubMed ID: 11984824
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
